Download the notification No. S.O. 4588(E) dated 29-09-2022, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 40 drug formulations, vide notification No. S.O. 4588(E) dated 29-09-2022.

Download the notification No. S.O. 4588(E) dated 29-09-2022

The notification reads as under:

In exercise of the powers conferred by paragraphs 5, 11, and 15 of the Drugs (PricesControl) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S.O. 701(E) dated 10th March 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred to as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Download the notification No. S.O. 4588(E) dated 29-09-2022

Note:(a) The manufacturer of the above-mentioned formulations, i.e., “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it ispayable to the Government on the retail price mentioned in column (6) of the above saidtable.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concernedmanufacturer in accordance with the retail price specified in column (6) of the above table.per the provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer will issuea price list in Form–V from the date of notification as per paragraph 24 of the DPCO, 2013 toNPPA through IPDMS and submit a copy to the State Drug Controller and dealers.

Click for more on NPPA

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display a price list and thesupplementary price list, if any, as furnished by the manufacturer, on a conspicuous part ofon the premises where he carries on business in a manner so as to be easily accessible to anya person wishing to consult it.

(e) The above-mentioned retail price is applicable only to the individual manufacturer/marketer as mentioned above, i.e., who has applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/rules, including manufacturing license permission from the Competent Authority i.e., the Centralthe Licensing Authority, as may be applicable, by the concerned manufacturer/marketingcompanies.

Click for more on DPCO 2013

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concernedmanufacturer/marketing company shall be liable to deposit the overcharged amount alongwith the interest thereon under the provisions of the DPCO, 2013 read with the EssentialCommodities Act, 1955.

(g) Consequent to the fixation of the retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Columns (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.

Latest on National Pharmaceutical Pricing Authority (NPPA)

Latest notifications – DPCO / NPPA

Latest Notifications: EC Act (Essential Commodities Act)

FAQs – On DPCO: Drugs (Prices Control) Order, 2013

API manufacturing finally getting the attention it deserves

USFDA gives nod for this generic drug for urinary issues

IPC launches 1000th IP Reference Standard

NDPS: Inter-state Pharmaceutical drug racket busted

USFDA issues 2 observations on Form 483 to Zydus Lifesciences

DCGI panel recommends ban on these Fixed dose combination drugs

Bar codes could come soon to stop the threat of sub-standard drugs

Govt notifies RDTL Chandigarh as Central Medical Devices Testing Laboratory

Drug recall: Acyclovir Sodium Injection recalled due to this reason

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/10/05/nppa-fixes-retail-prices-of-40-formulations-september-2022/